Sales of foreign multinational drug corporations on remarkable growth.

The rank of foreign drug corporations in terms of the 2005 sales volume seems to be changed and it is clear that a company selling over the level of 300 billion won may appear for the first since their business entries in Korea.

According to Yakup Press, the company rank showed Pfizer Korea as the top with over 300 billion won of sales, GSK the second with 302.5 BW who ranked the 3rd in 200...